Market Cap 3.77B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 69.26
Forward PE 116.61
Profit Margin -17.12%
Debt to Equity Ratio 0.18
Volume 513,600
Avg Vol 536,306
Day's Range N/A - N/A
Shares Out 28.91M
Stochastic %K 31%
Beta 2.01
Analysts Strong Sell
Price Target $157.88

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:17 AM
$WGS: The current market context shows a last close at $130.35, which is above the 30-day moving average (MA30) of $128.8 and significantly above the 50-day moving average (MA50) of $126.1, indicating a bullish trend. The RSI at 51.71 suggests the stock is neither overbought nor oversold, allowing for potential upward movement. The 60-day high of $147.71 and low of $104.49 provides a wide range for price action, supporting a bullish bias. Suggested entry is at $131.00, just above the last close to confirm upward momentum. Set a stop loss at $125.00 to manage risk. Target 1 is $140.00, near the previous resistance level, and Target 2 is $145.00, approaching the 60D high. This plan leverages the current technical indicators while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:49 AM
$WGS: The current market context shows a last close at $130.35, which is above the 30-day moving average (MA30) of $128.8 and significantly above the 50-day moving average (MA50) of $126.1, indicating a bullish trend. The RSI at 51.71 suggests the stock is neither overbought nor oversold, allowing for potential upward movement. The 60-day high of $147.71 and low of $104.49 provides a wide range for price action, supporting a bullish bias. Suggested entry is at $131.00, just above the last close to confirm upward momentum. Set a stop loss at $125.00 to manage risk. Target 1 is $140.00, near the previous resistance level, and Target 2 is $145.00, approaching the 60D high. This plan leverages the current technical indicators while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:56 AM
$WGS trade plan: Market context shows a last close at $139.91, with a high of $147.71 and a low of $104.49 over the past 60 days. The RSI at 72.78 indicates that the stock is in overbought territory, suggesting a potential pullback. The 30-day moving average (MA30) at $127.61 and the 50-day moving average (MA50) at $125.91 indicate a bullish trend, but the current price is significantly above these averages, reinforcing the overbought signal. Directional bias is bearish in the short term due to the high RSI, but bullish in the longer term based on moving averages. Suggested entry: $137.50 (if a pullback occurs). Stop: $134.00 (below recent support). Targets: $145.00 (first target) and $140.00 (second target), considering resistance levels. Monitor closely for confirmation of reversal signals. https://privateprofiteers.com
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 12 at 7:15 PM
$WGS nice conference call
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:31 AM
$WGS trade plan: Market context shows a last close at $139.91, with a high of $147.71 and a low of $104.49 over the past 60 days. The RSI at 72.78 indicates that the stock is in overbought territory, suggesting a potential pullback. The 30-day moving average (MA30) at $127.61 and the 50-day moving average (MA50) at $125.91 indicate a bullish trend, but the current price is significantly above these averages, reinforcing the overbought signal. Directional bias is bearish in the short term due to the high RSI, but bullish in the longer term based on moving averages. Suggested entry: $137.50 (if a pullback occurs). Stop: $134.00 (below recent support). Targets: $145.00 (first target) and $140.00 (second target), considering resistance levels. Monitor closely for confirmation of reversal signals. https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 9:02 PM
11/07 to 11/21 $WGS $WFRD $WELL $WDS $WDC 🔥
1 · Reply
IN0V8
IN0V8 Nov. 10 at 5:29 PM
$WGS Opportunity Piper Sandler raises target price to $160 from $140
0 · Reply
CarverX
CarverX Nov. 10 at 4:43 PM
$WGS Chart setup looking good 🚀🚀🚀
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 10 at 3:01 PM
0 · Reply
G_krupins
G_krupins Nov. 9 at 4:53 PM
$WGS Had a lot of stops hit last week so the good news is have flexibility for new adds. This one is on my list for next week
0 · Reply
Latest News on WGS
GeneDx to Participate in Upcoming Investor Conferences

Nov 4, 2025, 8:00 AM EST - 10 days ago

GeneDx to Participate in Upcoming Investor Conferences


GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 3:41 PM EDT - 17 days ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript


GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 4 weeks ago

GeneDx's Blueprint For The Next Healthcare Revolution


How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 4 weeks ago

How GeneDX CEO Katherine Stueland is using AI to save lives


Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 2 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER


GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 5:06 PM EDT - 3 months ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript


GeneDx: Strong Testing Volume And An Invaluable Genomic Database

Jul 15, 2025, 2:52 AM EDT - 4 months ago

GeneDx: Strong Testing Volume And An Invaluable Genomic Database


GeneDx: Time To Buy The Dip

May 14, 2025, 5:35 AM EDT - 6 months ago

GeneDx: Time To Buy The Dip


GeneDx Announces Completion of Fabric Genomics Acquisition

May 7, 2025, 8:30 AM EDT - 6 months ago

GeneDx Announces Completion of Fabric Genomics Acquisition


GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 1:15 PM EDT - 7 months ago

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript


GeneDx: Strengthening Leadership In Genomic Diagnostics

Apr 28, 2025, 11:13 AM EDT - 7 months ago

GeneDx: Strengthening Leadership In Genomic Diagnostics


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:17 AM
$WGS: The current market context shows a last close at $130.35, which is above the 30-day moving average (MA30) of $128.8 and significantly above the 50-day moving average (MA50) of $126.1, indicating a bullish trend. The RSI at 51.71 suggests the stock is neither overbought nor oversold, allowing for potential upward movement. The 60-day high of $147.71 and low of $104.49 provides a wide range for price action, supporting a bullish bias. Suggested entry is at $131.00, just above the last close to confirm upward momentum. Set a stop loss at $125.00 to manage risk. Target 1 is $140.00, near the previous resistance level, and Target 2 is $145.00, approaching the 60D high. This plan leverages the current technical indicators while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:49 AM
$WGS: The current market context shows a last close at $130.35, which is above the 30-day moving average (MA30) of $128.8 and significantly above the 50-day moving average (MA50) of $126.1, indicating a bullish trend. The RSI at 51.71 suggests the stock is neither overbought nor oversold, allowing for potential upward movement. The 60-day high of $147.71 and low of $104.49 provides a wide range for price action, supporting a bullish bias. Suggested entry is at $131.00, just above the last close to confirm upward momentum. Set a stop loss at $125.00 to manage risk. Target 1 is $140.00, near the previous resistance level, and Target 2 is $145.00, approaching the 60D high. This plan leverages the current technical indicators while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:56 AM
$WGS trade plan: Market context shows a last close at $139.91, with a high of $147.71 and a low of $104.49 over the past 60 days. The RSI at 72.78 indicates that the stock is in overbought territory, suggesting a potential pullback. The 30-day moving average (MA30) at $127.61 and the 50-day moving average (MA50) at $125.91 indicate a bullish trend, but the current price is significantly above these averages, reinforcing the overbought signal. Directional bias is bearish in the short term due to the high RSI, but bullish in the longer term based on moving averages. Suggested entry: $137.50 (if a pullback occurs). Stop: $134.00 (below recent support). Targets: $145.00 (first target) and $140.00 (second target), considering resistance levels. Monitor closely for confirmation of reversal signals. https://privateprofiteers.com
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 12 at 7:15 PM
$WGS nice conference call
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:31 AM
$WGS trade plan: Market context shows a last close at $139.91, with a high of $147.71 and a low of $104.49 over the past 60 days. The RSI at 72.78 indicates that the stock is in overbought territory, suggesting a potential pullback. The 30-day moving average (MA30) at $127.61 and the 50-day moving average (MA50) at $125.91 indicate a bullish trend, but the current price is significantly above these averages, reinforcing the overbought signal. Directional bias is bearish in the short term due to the high RSI, but bullish in the longer term based on moving averages. Suggested entry: $137.50 (if a pullback occurs). Stop: $134.00 (below recent support). Targets: $145.00 (first target) and $140.00 (second target), considering resistance levels. Monitor closely for confirmation of reversal signals. https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 9:02 PM
11/07 to 11/21 $WGS $WFRD $WELL $WDS $WDC 🔥
1 · Reply
IN0V8
IN0V8 Nov. 10 at 5:29 PM
$WGS Opportunity Piper Sandler raises target price to $160 from $140
0 · Reply
CarverX
CarverX Nov. 10 at 4:43 PM
$WGS Chart setup looking good 🚀🚀🚀
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 10 at 3:01 PM
0 · Reply
G_krupins
G_krupins Nov. 9 at 4:53 PM
$WGS Had a lot of stops hit last week so the good news is have flexibility for new adds. This one is on my list for next week
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 6 at 7:37 PM
0 · Reply
MaverikIT
MaverikIT Nov. 6 at 5:47 PM
$WGS -0.35 $TEM -7.55
0 · Reply
DARKP00L
DARKP00L Nov. 6 at 1:14 PM
$WGS 08:13 on Nov. 06 2025 GeneDx To Present Four Research Sessions At The 2025 National Society Of Genetic Counselors Annual Meeting, Showcasing Advances Powered By Its Genedx Infinity Platform #tradeideas
0 · Reply
11thestate
11thestate Nov. 5 at 3:57 PM
Imagine buying $WGS at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $WGS investors out there, we’ve got some important news for you: https://11th.com/cases/cmls-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11052025
0 · Reply
CarverX
CarverX Nov. 5 at 2:59 AM
$WGS Canaccord Genuity Initiates Coverage on GeneDx With Buy Rating, $155 Price Target 07:29:54 AM ET, 10/20/2025 - MT Newswires
0 · Reply
CarverX
CarverX Nov. 5 at 2:57 AM
$WGS William O'Neil Initiates GeneDx Holdings at Buy 07:15:52 AM ET, 10/30/2025 - MT Newswires - GeneDx Holdings (WGS) has an average rating of buy and mean price target of $151.22, according to analysts polled by FactSet.
0 · Reply
MaverikIT
MaverikIT Nov. 4 at 10:04 PM
$TEM -4.22 say hello to $WGS +1.18 - holding up while other$
0 · Reply
DARKP00L
DARKP00L Nov. 4 at 4:15 PM
$WGS 11:05 on Nov. 04 2025 Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Raises Price Target to $140 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 4:06 PM
Wells Fargo updates rating for GeneDx Holdings ( $WGS ) to Equal-Weight, target set at 95 → 140.
0 · Reply
Lambster2
Lambster2 Nov. 3 at 5:28 PM
$WGS Can someone tell me the strike price of the WGSWW warrants that expire Jul 26? TIA
2 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 3:16 PM
$WGS Great piece that accurately captures WGS's current position. So if you want to refresh your understanding of WGS or learn about WGS for the first time, this is essential reading. https://beyondspx.com/quote/WGS/analysis/genedx-unlocking-precision-health-with-genomic-data-and-ai-nasdaq-wgs
1 · Reply
MaverikIT
MaverikIT Nov. 3 at 2:56 PM
$WGS $WGS +4.15 - ahh someone saying this is 'tra$H' - eyeing 52wk$ $TEM
0 · Reply